The Role of Stereotactic Ablative Radiotherapy for Early-Stage and Oligometastatic Non-small Cell Lung Cancer:Evidence for Changing Paradigms

키워드

참고문헌 (83)

1. Loo BW, "Stereotactic ablative radiotherapy: what’s in a name", Pract Radiat Oncol, 1, pp.38~39 (2011)
2. Palma D, "Stereotactic radiation therapy: changing treatment paradigms for stage I nonsmall cell lung cancer", Curr Opin Oncol, 23, pp.133~139 (2011)
3. Hurkmans CW, "Recommendations for implementing stereotactic radiotherapy in peripheral stage IA non-small cell lung cancer: report from the Quality Assurance Working Party of the randomised phase III ROSEL study", Radiat Oncol, 4, pp.1~ (2009)
4. Verbakel WF, "Rapid delivery of stereotactic radiotherapy for peripheral lung tumors using volumetric intensitymodulated arcs", Radiother Oncol, 93, pp.122~124 (2009)
5. Timmerman R, "Stereotactic body radiation therapy for inoperable early stage lung cancer", JAMA, 303, pp.1070~1076 (2010)
6. Lagerwaard FJ, "Outcomes of riskadapted fractionated stereotactic radiotherapy for stage I non-small-cell lung cancer", Int J Radiat Oncol Biol Phys, 70, pp.685~692 (2008)
7. van Sörnsen de Koste JR, "Tumor location cannot predict the mobility of lung tumors: a 3D analysis of data generated from multiple CT scans", Int J Radiat Oncol Biol Phys, 56, pp.348~354 (2003)
8. Underberg RW, "Four-dimensional CT scans for treatment planning in stereotactic radiotherapy for stage I lung cancer", Int J Radiat Oncol Biol Phys, 60, pp.1283~1290 (2004)
9. Lagerwaard FJ, "Rotterdam Oncological Thoracic Study Group. Has 3-D conformal radiotherapy (3D CRT) improved the local tumour control for stage I non-small cell lung cancer", Radiother Oncol, 63, pp.151~157 (2002)
10. Cheung PC, "Accelerated hypofractionation for early-stage non-small-cell lung cancer", Int J Radiat Oncol Biol Phys, 54, pp.1014~1023 (2002)
11. Palma D, "Impact of introducing stereotactic lung radiotherapy for elderly patients with stage I non-smallcell lung cancer: a population-based time-trend analysis", J Clin Oncol, 28, pp.5153~5159 (2010)
12. Nagata Y, "Survey of stereotactic body radiation therapy in Japan by the Japan 3-D Conformal External Beam Radiotherapy Group", Int J Radiat Oncol Biol Phys, 75, pp.343~347 (2009)
13. Grutters JP, "Comparison of the effectiveness of radiotherapy with photons, protons and carbonions for non-small cell lung cancer: a meta-analysis", Radiother Oncol, 95, pp.32~40 (2010)
14. Haasbeek CJ, "Stage I nonsmall cell lung cancer in patients aged ＞or =75 years: outcomes after stereotactic radiotherapy", Cancer, 116, pp.406~414 (2010)
15. Louie AV, "Withholding stereotactic radiotherapy in elderly patients with stage I non-small cell lung cancer and co-existing COPD is not justified: outcomes of a Markov Model analysis", Radiat Oncol, 99, pp.161~165 (2011)
16. Palma D, "Curative treatment of stage I non-small cell lung cancer in patients with severe COPD: stereotactic radiotherapy outcomes and systematic review", Int J Radiat Oncol Biol Phys (2011)[DOI]
17. Ball D, "Extracranial stereotactic body radiotherapy for stage I non-small cell lung cancer: still investigational or standard of care", J Thorac Oncol, 3, pp.1209~1210 (2008)
18. Soliman H, "Accelerated hypofractionated radiotherapy for early-stage non-small-cell lung cancer: long-term results", Int J Radiat Oncol Biol Phys, 79, pp.459~465 (2011)
19. Cooperberg MR, "Time trends and local variation in primary treatment of localized prostate cancer", J Clin Oncol, 28, pp.1117~1123 (2010)
20. Mintz A, "Management of single brain metastasis: a practice guideline", Curr Oncol, 14, pp.131~143 (2007)
21. Grossman J, "The randomized controlled trial: gold standard, or merely standard", Perspect Biol Med, 48, pp.516~534 (2005)
22. Bentzen SM, "Radiation oncology health technology assessment: the best is the enemy of the good", Nat Clin Pract Oncol, 5, pp.563~ (2008)
23. Weijer C, "For and against: clinical equipoise and not the uncertainty principle is the moral underpinning of the randomised controlled trial", BMJ, 321, pp.756~758 (2000)
24. Wisnivesky JP, "Effectiveness of radiation therapy for elderly patients with unresected stage I and II non-small cell lung cancer", Am J Respir Crit Care Med, 181, pp.264~269 (2010)
25. study), "Int J Radiat Oncol Biol Phys", 2011, 918~927
26. Pan H, "A survey of stereotactic body radiotherapy use in the United States", Cancer (2011)[DOI]
27. Dahele M, "Radiation oncology: overview and recent advances", J R Coll Physicians Edinb, 40, pp.136~143 (2010)
28. Onishi H, "Hypofractionated stereotactic radiotherapy (HypoFXSRT) for stage I non-small cell lung cancer: updated results of 257 patients in a Japanese multi-institutional study", J Thorac Oncol, 2(7), pp.S94~S100 (2007)
29. Park C, "Universal survival curve and single fraction equivalent dose: useful tools in understanding potency of ablative radiotherapy", Int J Radiat Oncol Biol Phys, 70, pp.847~852 (2008)
30. Olsen JR, "Doseresponse for stereotactic body radiotherapy in early-stage non-small-cell lung cancer", Int J Radiat Oncol Biol Phys (2011)[DOI]
31. Chi A, "Systemic review of the patterns of failure following stereotactic body radiation therapy in early-stage non-small-cell lung cancer: clinical implications", Radiother Oncol, 94, pp.1~11 (2010)
32. Milano MT, "Normal tissue toxicity after small field hypofractionated stereotactic body radiation", Radiat Oncol, 3, pp.36~ (2008)
33. Forquer JA, "Brachial plexopathy from stereotactic body radiotherapy in early-stage NSCLC: doselimiting toxicity in apical tumor sites", Radiother Oncol, 93, pp.408~413 (2009)
34. Ong CL, "Treatment of large stage I-II lung tumors using stereotactic body radiotherapy (SBRT): planning considerations and early toxicity", Radiother Oncol, 97, pp.431~436 (2010)
35. Song SY, "Fractionated stereotactic body radiation therapy for medically inoperable stage I lung cancer adjacent to central large bronchus", LUNG CANCER, 66(1), pp.89~93 (2009), Elsevier
36. Timmerman R, "Excessive toxicity when treating central tumors in a phase II study of stereotactic body radiation therapy for medically inoperable early-stage lung cancer", Clin Oncol, 24, pp.4833~4839 (2006)
37. Haasbeek CJ, "Critical review of nonsurgical treatment options for stage I non-small cell lung cancer", Oncologist, 13, pp.309~319 (2008)
38. Timmerman RD, "Surgery versus stereotactic body radiation therapy for early-stage lung cancer: who's down for the count", J Clin Oncol, 28, pp.907~909 (2010)
39. Louie AV, "Stereotactic body radiotherapy versus surgery for medically operable stage I non-small-cell lung cancer: a Markov Model-based decision analysis", Int J Radiat Oncol Biol Phys (2010)[DOI]
40. Crabtree TD, "Stereotactic body radiation therapy versus surgical resection for stage I non-small cell lung cancer", J Thorac Cardiovasc Surg, 140, pp.377~386 (2010)
41. Boyd JA, "Timing of local and distant failure in resected lung cancer: implications for reported rates of local failure", J Thorac Oncol, 5, pp.211~214 (2010)
42. Warren JL, "Evaluation of trends in the cost of initial cancer treatment", J Natl Cancer Inst, 100, pp.888~897 (2008)
43. Pepe C, "Adjuvant vinorelbine and cisplatin in elderly patients: National Cancer Institute of Canada and Intergroup Study JBR.10", J Clin Oncol, 25, pp.1553~1561 (2007)
44. Felip E, "Preoperative chemotherapy plus surgery versus surgery plus adjuvant chemotherapy versus surgery alone in early-stage non-small-cell lung cancer", J Clin Oncol, 28, pp.3138~3145 (2010)
45. Herder GJ, "Clinical prediction model to characterize pulmonary nodules: validation and added value of 18F-fluorodeoxyglucose positron emission tomography", Chest, 128, pp.2490~2496 (2005)
46. van Tinteren H, "Effectiveness of positron emission tomography in the preoperative assessment of patients with suspected non-small-cell lung cancer: the PLUS multicentre randomised trial", Lancet, 359, pp.1388~1393 (2002)
47. fluorodeoxyglucose-positron emission tomography staging of non-small-cell lung cancer: a Dutch cooperative randomized study, "J Clin Oncol", 2006, 1800~1806
48. Belgers EH, "Complete video-assisted thoracoscopic surgery lobectomy and its learning curve: a single center study introducing the technique in The Netherlands", Interact Cardiovasc Thorac Surg, 10, pp.176~180 (2010)
49. May BJ, "Should CT play a greater role in preventing the resection of granulomas in the era of PET", AJR Am J Roentgenol, 196, pp.795~800 (2011)
50. Dahele M, "Radiological changes following stereotactic radiotherapy for stage I lung cancer", J Thorac Oncol (2011)[DOI]
51. Neri S, "Surgical treatment of local recurrence after stereotactic body radiotherapy for primary and metastatic lung cancers", J Thorac Oncol, 5, pp.2003~2007 (2010)
52. Chen F, "Salvage lung resection for non-small cell lung cancer after stereotactic body radiotherapy in initially operable patients", J Thorac Oncol, 5, pp.1999~2002 (2010)
53. Allen MS, "Morbidity and mortality of major pulmonary resections in patients with early-stage lung cancer: initial results of the randomized, prospective ACOSOG Z0030 trial", Ann Thorac Surg, 81, pp.1013~1019 (2006)
54. Kates M, "Validation of a model to predict perioperative mortality from lung cancer resection in the elderly", Am J Respir Crit Care Med, 179, pp.390~395 (2009)
55. O'Connor GT, "A regional intervention to improve the hospital mortality associated with coronary artery bypass graft surgery. The Northern New England Cardiovascular Disease Study Group", JAMA, 275, pp.841~846 (1996)
56. Finley CJ, "The effect of regionalization on outcome in pulmonary lobectomy: a Canadian national study", J Thorac Cardiovasc Surg, 140, pp.757~763 (2010)
57. "Clinical practice guidelines for the treatment of unresectable non-small-cell lung cancer. Adopted on May 16, 1997 by the American Society of Clinical Oncology", J Clin Oncol, 15, pp.2996~3018 (1997)
58. Schiller JH, "Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer", N Engl J Med, 346, pp.92~98 (2002)
59. Burt M, "Resection of brain metastases from nonsmall- cell lung carcinoma. Results of therapy. Memorial Sloan-Kettering Cancer Center Thoracic Surgical Staff", J Thorac Cardiovasc Surg, 103, pp.399~410 (1992)
60. Luketich JD, "Does resection of adrenal metastases from non-small cell lung cancer improve survival", Ann Thorac Surg, 62, pp.1614~1616 (1996)
61. Lind JS, "Time for reappraisal of extracranial treatment options? Synchronous brain metastases from nonsmall cell lung cancer", Cancer, 117, pp.597~605 (2011)
62. Fairchild A, "Palliative thoracic radiotherapy for lung cancer: a systematic review", J Clin Oncol, 26, pp.4001~4011 (2008)
63. Rusthoven KE, "Is there a role for consolidative stereotactic body radiation therapy following firstline systemic therapy for metastatic lung cancer? A patterns-of-failure analysis", Acta Oncol, 48, pp.578~583 (2009)
64. Marks LB, "Stage III vs. stage IV lung cancer: Crossing a Great Divide", Lung Cancer, 67, pp.1~3 (2010)
65. Lim E, "Guidelines on the radical management of patients with lung cancer", Thorax, 65(3), pp.iii1~iii27 (2010)
66. Rusthoven KE, "Multi-institutional phase I", II trial of stereotactic body radiation therapy for liver metastases, 2009, pp.27, 1572~1578
67. Casamassima F, "Stereotactic radiotherapy for adrenal gland metastases: University of Florence experience", Int J Radiat Oncol Biol Phys (2011)[DOI]
68. Rusthoven KE, "Multiinstitutional phase I", II trial of stereotactic body radiation therapy for lung metastases, 2009, pp.27, 1579~1584
69. Wegner RE, "Stereotactic radiosurgery for patients with brain metastases from small cell lung cancer", Int J Radiat Oncol Biol Phys (2011)[DOI]
70. Lovelock DM, "Correlation of local failure with measures of dose insufficiency in the high-dose single-fraction treatment of bony metastases", Int J Radiat Oncol Biol Phys, 77, pp.1282~1287 (2010)
71. Hellman S, "Oligometastases", J Clin Oncol, 13, pp.8~10 (1995)
72. Mehta N, "Analysis of further disease progression in metastatic non-small cell lung cancer: implications for locoregional treatment", Int J Oncol, 25, pp.1677~1683 (2004)
73. Rosell R, "Screening for epidermal growth factor receptor mutations in lung cancer", N Engl J Med, 361, pp.958~967 (2009)
74. Mok TS, "Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma", N Engl J Med, 361, pp.947~957 (2009)
75. Kwak EL, "Anaplastic lymphoma kinase inhibition in non-small-cell lung cancer", N Engl J Med, 363, pp.1693~1703 (2010)
76. Sun Y, "Lung adenocarcinoma from East Asian never-smokers is a disease largely defined by targetable oncogenic mutant kinases", J Clin Oncol, 28, pp.4616~4620 (2010)
77. Soria JC, "Hemorrhage caused by antiangiogenic therapy within previously irradiated areas: expected consequence of tumor shrinkage or a warning for antiangiogenic agents combined to radiotherapy", Ann Oncol, 22, pp.1247~1249 (2011)
78. Senan S, "Design of clinical trials of radiation combined with antiangiogenic therapy", Oncologist, 12, pp.465~477 (2007)
79. Klein EE, "Task Group 142 report: quality assurance of medical accelerators", Med Phys, 36, pp.4197~4212 (2009)
80. Kuijper IT, "Volumetric modulated arc therapy versus conventional intensity modulated radiation therapy for stereotactic spine radiotherapy: a planning study and early clinical data", Radiother Oncol, 94, pp.224~228 (2010)
81. Dahele M, "Imaging for stereotactic spine radiotherapy: clinical considerations", Int J Radiat Oncol Biol Phys
82. Woodington GF, "Results of resection of metastatic tumors of the liver", Am J Surg, 105, pp.24~29 (1963)
83. Garden OJ, "Guidelines for resection of colorectal cancer liver metastases", Gut, 55(3), pp.iii1~iii8 (2006)

관련 논문AI추천